Chester County News and Community Website
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) announced that the U.S. Patent and Trademark Office recently issued U.S. Patent No. 11,576,911.
NRx Pharmaceuticals Receives Patent for Neuropsychiatric Treatments Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the United States Patent and Trademark Office (USPTO) recently issued U.S. Patent No. 11,583,540, providing expanded patent coverage for istaroxime …
Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office Read More
BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the recent filing of a patent application that extends the breadth of its platform from neurodegenerative to neuropsychiatric indications: “Treatment of mental illness via …
Annovis Bio Announces Filing of Patent Covering the Administration of Buntanetap Read More
PHILADELPHIA, PA — FullThrottle Technologies, LLC this week announced the issuance of the company’s first patent by the United States Patent and Trademark Office. U.S. Patent No. 11,556,947 helps protect …
FullThrottle Technologies, LLC Announces Issuance of Patent for Company’s Proprietary First-Party Data Technologies Read More
WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) announced the recent issuance of Chinese Patent CN109153641B covering MTTI’s lead radiotherapeutic product, EBTATE™ and others in its EvaThera™ platform. Approval …
MTTI Receives Chinese Patent for EVATHERA Technology Read More
TREVOSE, PA —Lannett Company, Inc. (NYSE: LCI) announced that it recently entered into an agreement with Ypsomed AG, the manufacturer and supplier of the pen injector device to be used in …
Lannett Announces Patent Licenses for the Pen Injector Delivery Device Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced that the U.S. Patent and Trademark Office recently issued Patent No. 11,458,109, titled “Treatment of 22q11.2 Deletion Syndrome With Cannabidiol,” which …
Zynerba Pharmaceuticals Announces Issuance of New U.S. Patent for Zygel Read More
PHILADELPHIA, PA — VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE: VSBY) (Frankfurt 5VS) announced that the U.S. Patent and Trademark Office recenlty issued patent No. 11,481,809 for the firm’s software …
VSBLTY Awarded U.S. Patent for Innovative Content Management System Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced the recent issuance of U.S. Patent No. 11,459,363. The patent, titled, “Materials and Methods for Treating Friedreich’s Ataxia,” provides composition …
Larimar Therapeutics Announces Issuance of U.S. Patent Providing Composition of Matter Protection for CTI-1601 Read More DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced that the U.S. Patent and Trademark Office recently issued Patent No. 11,458,110, titled “Treatment of Fragile X Syndrome With Cannabidiol,” which …
Zynerba Pharmaceuticals Announces Issuance of New U.S. Patent for Zygel Read More